“…In both diagnostics and therapeutics, nanoparticles represent an alternative to traditional radiation-based modalities . Whereas MIBG relies on radiation signatures to achieve spatial resolution, nanoparticles can be easily labeled with nonradio modalities (fluorescence, photoacoustic) for identification in the tissue. , Many nanoparticle platforms can be easily loaded with therapeutics, including single components or combinations thereof, of chemotherapeutics, photodynamic, or photothermal agents. − For tumor tissues specifically, nanoparticles are even known to naturally (“passively”) accumulate, a process known as the enhanced permeability and retention (EPR) effect. , Despite having a nanocarrier size (>20 nm) far larger than the NET pore, MIBG-inspired compounds conjugated to nanoparticle surfaces have been reported to exhibit over a 4× increase in uptake compared with nonconjugated controls in neuroblastoma (NB) cell lines. , …”